- Home
- SNDL vs RCKT Comparison
SNDL vs RCKT Comparison
Compare SNDL & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDL
- RCKT
- Stock Information
- Founded
- SNDL 2006
- RCKT 1999
- Country
- SNDL Canada
- RCKT United States
- Employees
- SNDL N/A
- RCKT N/A
- Industry
- SNDL Pharmaceuticals and Biotechnology
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- SNDL Health Care
- RCKT Health Care
- Exchange
- SNDL Nasdaq
- RCKT Nasdaq
- Market Cap
- SNDL 651.1M
- RCKT 328.6M
- IPO Year
- SNDL 2019
- RCKT N/A
- Fundamental
- Price
- SNDL $2.68
- RCKT $3.28
- Analyst Decision
- SNDL
- RCKT Buy
- Analyst Count
- SNDL 0
- RCKT 13
- Target Price
- SNDL N/A
- RCKT $12.96
- AVG Volume (30 Days)
- SNDL 4.9M
- RCKT 6.0M
- Earning Date
- SNDL 07-31-2025
- RCKT 08-07-2025
- Dividend Yield
- SNDL N/A
- RCKT N/A
- EPS Growth
- SNDL N/A
- RCKT N/A
- EPS
- SNDL N/A
- RCKT N/A
- Revenue
- SNDL $692,339,389.00
- RCKT N/A
- Revenue This Year
- SNDL $5.52
- RCKT N/A
- Revenue Next Year
- SNDL $4.09
- RCKT $108.43
- P/E Ratio
- SNDL N/A
- RCKT N/A
- Revenue Growth
- SNDL 3.54
- RCKT N/A
- 52 Week Low
- SNDL $1.15
- RCKT $2.19
- 52 Week High
- SNDL $2.74
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- SNDL 82.41
- RCKT 51.17
- Support Level
- SNDL $2.07
- RCKT $2.88
- Resistance Level
- SNDL $2.74
- RCKT $3.74
- Average True Range (ATR)
- SNDL 0.14
- RCKT 0.27
- MACD
- SNDL 0.05
- RCKT 0.02
- Stochastic Oscillator
- SNDL 92.50
- RCKT 35.43
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.